Table 2:

Hemorrhage subtypes in PRES: relationship to clinical associations and adverse clinical outcomes

Toxicity Association	Total No. Pts with PRES	Patients with PRES and Hemorrhage
		No. Pts with Hemorrhage	Hemorrhage Subtypes (No. Pts)
		No. Pts with Hemorrhage	Minute	Sulcal	Hematoma
Immunosuppression^‡	50	11	5	4	3
Solid-organ transplant	34	4	4 (1D)	1	0
Allo-BMT	15	7	1 (1D)	3 (1D)	3 (2D)
Other^†	1	0	0	0	0
Infection/sepsis/shock	52	6	4	1	4 (1D)
Autoimmune	12	2	2^*	0	2^*
Chemotherapy	10	1	1	0	0
Eclampsia	18	1	0	1	1
Unknown	9	2	0	1	1
Total	151	23	12	7	11

Note:—D indicates that the patient died.
* A single patient with autoimmune disease and both minute hemorrhage and focal hematoma who sustained a permanent deficit (homonymous hemianopsia, hemiparesis, and facial droop).
† A single patient with psoriasis on cyclosporine.
‡ Transplant, on cyclosporine, or tacrolimus (FK-506).